2024/04/26 22:30:01 | |
---|---|
Price | |
2.422 USD | |
Difference | 0.92% (0.02) |
ISIN | US98386D3070 |
Symbol | XTLB |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 0 |
Benchmark | MSCI WORLD INDEX (STRD, UHD) |
Bid (Bid size) | 2.20 USD (5,000) |
Ask (Ask size) | 2.70 USD (200) |
Open | 2.49 USD |
High | 2.49 USD |
Low | 2.405 USD |
Close (prev. day) | 2.40 USD |
VWAP | 2.433191 USD |
Volume (pcs) | 5,253 |
Trading volume | 12,792.48 |
Number of trades | 37 |
Last size | - |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/04/26 | Global Equity Ratings | ||
2024/04/03 | Global Equity Ratings | ||
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings |
2024/04/26 22:30:01 | |
---|---|
Price | |
2.422 USD | |
Difference | 0.92% (0.02) |
ISIN | US98386D3070 |
Symbol | XTLB |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 0 |
Benchmark | MSCI WORLD INDEX (STRD, UHD) |
Bid (Bid size) | 2.20 USD (5,000) |
Ask (Ask size) | 2.70 USD (200) |
Open | 2.49 USD |
High | 2.49 USD |
Low | 2.405 USD |
Close (prev. day) | 2.40 USD |
VWAP | 2.433191 USD |
Volume (pcs) | 5,253 |
Trading volume | 12,792.48 |
Number of trades | 37 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | +195.33% | +101.83% | -26.83% |
Perf (abs.) | +1.60 | +1.22 | -0.89 |
Beta | 0.89 | -0.01 | 0.54 |
Volatility | 147.26 | 121.40 | 88.59 |
Ø price 5 days | Ø volume 5 days (pcs.) | 2.524 USD (16,004) |
Ø price 30 days | Ø volume 30 days (pcs.) | 2.571 USD (1,571,509) |
Ø price 100 days | Ø volume 100 days (pcs.) | 1.514 USD (473,678) |
Ø price 250 days | Ø volume 250 days (pcs.) | 1.217 USD (194,923) |
YTD High | date | 4.990 USD (2024/03/25) |
YTD Low | date | 0.768 USD (2024/02/26) |
52 Weeks High | date | 4.990 USD (2024/03/25) |
52 Weeks Low | date | 0.750 USD (2023/07/25) |
XTL BIOPHARMACEUTICALS LTD |
- - |
Kiryat Weizmann, Science Pk, Bldg 3 - 76100 Rehovot |
Telefon: +972-8-930-4444 |
Fax: +972-8-930-4445 |
E-mail: IR@xtlbio.com |
- |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer